NYSE: ALL · Financials · Insurance

The Allstate Corporation

Allstate is a US personal-lines property and casualty insurer selling auto, homeowners and other cover through exclusive agents, independent agencies and direct channels.

Our rating
Buy
12-month target
$309.41
Price, Nov 18, 2026
$266.59
Expected return, with dividend
+18%

Latest research: initiation, Nov 21, 2026Market value $66.3bn

ALLBuyTarget $309.41+18% expected
Our ALL model 15 sheets: Summary, Thesis, Market Check, Assumptions, … · Updated Nov 22, 2026 Free to view Open the model
$266.59Price $309.4112-month target
Implied return +16% to our target. Bear to bull $220.58 to $393.35, from our initiation of Nov 21, 2026. We expect a total return of more than 10% over the next 12 months: the move to our price target, plus dividends.

Residual income on adjusted common book value at a 9.21% cost of equity (5.07% risk-free rate, 1.0 beta, 4.14% equity risk premium) and 0% terminal residual-income growth gives a $305.91 base value today. Bear, base and bull values today of $205.02, $305.91 and $365.60 are weighted 30/50/20% to $287.58 and rolled 12 months at cost of equity less the 1.62% dividend yield to the $309.41 target. A 10.9x peer trailing P/E cross-check gives $243.87.

Bear case
$220.58
-17% from $266.59
  • FY28E repeats the 2022 auto trough at 103.6% underlying
  • Adverse reserve additions (−4.2%)
  • FY23-level catastrophes
  • Normalised combined ratio 96.5%
Base case
$329.12
+23% from $266.59
  • Auto combined ratio drifts to mid-90s by FY28E
  • Normalised P-L combined ratio 94.0%
  • Modest reserve releases fade by FY29E
  • Normal catastrophes; yields reach 5.0%
Bull case
$393.35
+48% from $266.59
  • Auto underlying ratio held near 92%
  • Normalised P-L combined ratio 92.5%
  • Ongoing reserve releases and benign weather
  • 5.1% yield; NY and direct share gains
Base value (residual income)
$305.91
Cost of equity
9.21%
Terminal residual-income growth
0.0%
Price-implied normalised P-L CR
96.0%
Normalised ROE
18.7%
Peer trailing P/E cross-check
$243.87
P/E FY27E
9.0x
P/B (adj.) FY26E
1.95x

Our estimates

LineFY26EFY27EFY28E
Revenue$60.1bn$63.8bn$68.0bn
EPS$40.63$29.46$31.32
Consensus$37.90$27.58—
Ours vs consensus+7.2%+6.8%—

Sign in to Penmark